Changing the Game Against Cancer – Time for New Thinking
The former CEO and President of Eli Lilly offers thoughts on changing the game against cancer in a Wall Street Journal op-ed article. The...
The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
Changing the Game Against Cancer – Time for New Thinking
World Cancer Day 2014 – Data on New Cancers and Deaths
Pro Bono Advocacy Opportunities for Persons with Cancer – Maybe a New Resolution for 2014?
Honoring Others at Christmas – Cancer-related Giving
Until Year End, 2x Match for Donations to Mesothelioma Research at MARF
Reasons to Invest in Science – So Many Blood Cancers, and New Hope from Great New Science R
Adoption of New MicroRNA Technology for Cancers
Case Report on Simultaneous Lung Cancer and Localized Mesoethelioma
Fall Out from Myriad – New Gene Patent Testing and Prices Are Starting to Fall
AML, Lung Cancer, Benzene, Smoking and Epigenetics – More Evidence that Epigenetics Matters
Wonder Drugs, and Sequencing Tumor Mutations
An Impetus Towards More Benzene Litigation ? Higher Cancer Incidence in Persons Living Near Georgia
Mryiad’s Arguments to Enjoin Some Entities Testing for BRCA Genes
Good Words from a “Cancer Thriver”
Gene Patent Battles Expand as Myriad Sues Again Over BRCA Genes
The Gene Patent Wars Continue – Myriad Files Suit to Enjoin BRACA Testing
Guidelines for Molecular Testing for Lung Cancers
Cancer – The Emperor of All Maladies to Become a Six Hour Series on PBS
New Phases in Treating Cancer – Economic Implications for Litigation and Otherwise
How Much Should One Expect Lung Cancer Claiming to Increase Now that Low Dose CT Scans are Cheap and